Can a bedside heart ultrasound save lives in cirrhosis patients with sepsis?
NCT ID NCT07286643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ways to manage fluids in cirrhosis patients with severe sepsis or septic shock. One method uses a bedside heart ultrasound (POCUS) to guide fluid amounts, while the other follows standard sepsis guidelines. The goal is to see if ultrasound-guided care reduces the amount of fluid needed and prevents complications like fluid buildup in the lungs. The trial will enroll 140 critically ill adults in the ICU.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Point-of-care echocardiogram (POCUS) guided fluid resuscitation
What this could lead to
If successful, this could establish a better way to manage fluids in cirrhosis patients with sepsis, potentially reducing lung complications and improving survival.
What could go wrong
This is a small, early feasibility trial (140 participants) at a single center. The approach may not show clear benefits over standard care, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PGIMER Chandigarh
RECRUITINGChandigarh, 160012, India